Recent Change of -4.30% in the TG Therapeutics Inc. (TGTX) market price might lead to pleasant surprises

Let’s start up with the current stock price of TG Therapeutics Inc. (TGTX), which is $23.66 to be very precise. The Stock rose vividly during the last session to $26.05 after opening rate of $25.53 while the lowest price it went was recorded $24.64 before closing at $24.72.

TG Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $27.62 on 09/02/20, with the lowest value was $6.34 for the same time period, recorded on 03/18/20.

TG Therapeutics Inc. (TGTX) full year performance was 325.47%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, TG Therapeutics Inc. shares are logging -14.34% during the 52-week period from high price, and 377.94% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $4.95 and $27.62.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 934333 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the TG Therapeutics Inc. (TGTX) recorded performance in the market was 122.70%, having the revenues showcasing 35.68% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 3.00B, as it employees total of 176 workers.

The Analysts eye on TG Therapeutics Inc. (TGTX)

According to the data provided on, the moving average of the company in the 100-day period was set at 21.28, with a change in the price was noted +10.92. In a similar fashion, TG Therapeutics Inc. posted a movement of +87.64% for the period of last 100 days, recording 2,114,619 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for TGTX is recording 0.15 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.11.

Technical rundown of TG Therapeutics Inc. (TGTX)

Raw Stochastic average of TG Therapeutics Inc. in the period of last 50 days is set at 57.39%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 23.88%. In the last 20 days, the company’s Stochastic %K was 45.42% and its Stochastic %D was recorded 56.65%.

Considering, the past performance of TG Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 122.70%. Additionally, trading for the stock in the period of the last six months notably improved by 148.44%, alongside a boost of 325.47% for the period of the last 12 months. The shares increased approximately by -0.48% in the 7-day charts and went down by 6.92% in the period of the last 30 days. Common stock shares were driven by 35.68% during last recorded quarter.